Why is Medicamen Biotec falling/rising?

As of 15-Oct, Medicamen Biotech Ltd's stock price is rising, currently at Rs 319.00, reflecting an increase of Rs 13.25 or 4.33%. The stock has shown a positive trend today, gaining after two consecutive days of decline. It outperformed its sector by 4.25% and reached an intraday high of Rs 326.25, which is a 6.7% increase. Despite a negative performance over the past month and year, where the stock is down 7.00% and 42.02% respectively, the recent uptick in delivery volume, which rose by 118.53% against the 5-day average, indicates a growing interest among investors. However, the stock remains below its longer-term moving averages, suggesting that while there is a short-term recovery, the overall trend may still be under pressure.
Broader Market Context: In the short term, Medicamen Biotech's stock has outperformed the Sensex, which increased by only 1.02% over the past week, while the stock itself rose by 8.28%. This indicates that the recent price movement may be driven by specific factors related to the company rather than broader market trends. The stock's liquidity appears adequate for trading, which could also contribute to its recent price rise. Overall, while the stock is experiencing a momentary rebound, its long-term performance remains significantly weaker compared to the benchmark, highlighting ongoing challenges for the company.